Angiodynamics Stock Investor Sentiment
| ANGO Stock | USD 6.99 0.16 2.34% |
About 72 percent of all AngioDynamics' investors are curious in acquiring. The analysis of overall sentiment of trading AngioDynamics stock suggests that quite a few investors are confidant at this time. AngioDynamics' investing sentiment overview a quick insight into current market opportunities from investing in AngioDynamics. Many technical investors use AngioDynamics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
AngioDynamics |
AngioDynamics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards AngioDynamics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about AngioDynamics that are available to investors today. That information is available publicly through AngioDynamics media outlets and privately through word of mouth or via AngioDynamics internal channels. However, regardless of the origin, that massive amount of AngioDynamics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AngioDynamics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AngioDynamics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AngioDynamics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AngioDynamics alpha.
AngioDynamics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | AngioDynamics Stock Falls Despite CE Mark for Auryon System | 09/04/2024 |
2 | AngioDynamics Reports Q1 Loss, Misses Revenue Estimates | 10/03/2024 |
3 | AngioDynamics Loses -15.86 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner | 10/08/2024 |
4 | West Pharmaceutical Stock Gains on Q3 Earnings Beat Raised Guidance | 10/24/2024 |
5 | AngioDynamics adds US30m to market cap in the past 7 days, though investors from three years ago are still down 75 | 10/25/2024 |
6 | Acquisition by James Clemmer of 56279 shares of AngioDynamics subject to Rule 16b-3 | 10/30/2024 |
7 | CAH Stocks Gains on Q1 Earnings Sales Beat and Raised 25 EPS View | 11/01/2024 |
8 | Tempus Stock Declines Despite Q3 Earnings Revenues Beat Estimates | 11/05/2024 |
9 | XRAY Q3 Earnings Revenues Beat Estimates, 2024 Guidance Revised | 11/07/2024 |
10 | BRKR Stock Declines Despite Launching EpicIF Technology for CellScape | 11/11/2024 |
11 | GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System | 11/14/2024 |
12 | HealthEquity Gains 54.6 percent YTD Whats Driving the Stock | 11/20/2024 |
13 | DexCom and OURA Ink Partnership for Metabolic Health Innovation | 11/22/2024 |
Check out AngioDynamics Hype Analysis, AngioDynamics Correlation and AngioDynamics Performance. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.05) | Revenue Per Share 7.249 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.78) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.